PRENW Company Profile and Key Details

PRENW has shown mixed momentum, gaining 15.95% over the past week and -73.42% over the past quarter, though year-to-date performance is down -73.42%. Average 10-day trading volume of 4.20 thousand shares is below the 3-month average of 73.43 thousand, indicating normal recent market interest.

Prenetics Global Limited earnings surprise history is a mixed track record. The quarter that ended August 18, 2026, missed forecasts by -16.54%. The prior quarter beat by 58.36%. Over the last six quarters, Apple has recorded several small beats. These include 31.94% in September 12, 2025.

The stock is currently mid-range between its 52-week high and low $0.01 and $0.02. With a market capitalization of about $325.80 million, Prenetics Global Limited is classified as a small-cap and shows lower-than-market volatility (beta ~0.25). Key stats such as the average daily volume over the past year has been around 31.68 thousand shares, volume is running light vs its 52-week average. Headquartered in Hong Kong, , Prenetics Global Limited operates in the Healthcare sector and the Medical - Diagnostics & Research industry. Led by CEO Sheng Wu Yeung, the company employs approximately 98 people and listed since July 16, 2021. Prenetics Global Limited operates as an investment holding company specializing in diagnostics and genetic testing.

Prenetics Global Limited last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$18.54. This means the shares are trading below this model’s fair value.

Our AI price prediction model suggests that Prenetics Global Limited stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -22.48%, with price expected at $0.01 by November 23, 2023, within a range of $0.01 to $0.01

Prenetics Global Limited (NASDAQ:PRENW) shares are down -73.42% year-to-date Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Prenetics Global Limited trading at a premium to the broader market with a P/E of -5.61.

Prenetics Global Limited trades at a P/E ratio of -5.61, slightly below the S&P 500 average, with a price-to-sales ratio of 2.78 and a price-to-book ratio of 4.33 trading at moderately above to book value. The P/FCF stands at -11.62, also below market averages.